Healthy Returns: Biotech IPOs ramped up to start 2024, but the market hasn't fully recovered just yet 0 23.04.2024 19:57 CNBC Biotech IPOs surged at the start of 2024, but the rest of the year will depend on Fed rate cuts. Meanwhile, doctors using VR and AI to hone their skills. Партнёры Smi24.net Все новости за 24 часа Музыкальные новости Агрегатор новостей 24СМИ
